Tagged with Orphan Drugs

How Today’s Specialty Medicines are Driving the Future of Engagement
Fabrizio Chines – President & CEO, SIFI
Key Features of Orphan Drug Registration in Singapore, Malaysia, Philippines, and Vietnam
Orphan Drugs: Building the Regulatory Framework in the Czech Republic
David López García – Country Manager, BioMarin Mexico
Tamás Demeter – Country Manager, AOP Orphan, Hungary
Jan Krejčí – Country Manager, Ewopharma, Czech Republic
Myriam Hakim – General Manager GCC, Kyowa Kirin (January 2020)
UAE: A World Leader for Early Access to Innovation
A New Paradigm for Rare Diseases in China
Orphan Drug Accessibility & Social Medical Coverage in China
5 Key Trends in Orphan Drugs & Rare Diseases
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here